£154k
−44%vs Mar 2024Active05462441Private limited companyChipping Campden
MEDICINES DEVELOPMENT & LICENSING LTD
Significant control: Jonathan Douglas Collins (25–50%), Jennifer Elizabeth Collins (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Medicines Development & Licensing Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
MEDICINES DEVELOPMENT & LICENSING LTD is an active private limited company (company number 05462441) incorporated on 24 May 2005, registered in Chipping Campden. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of £154k and cash of £2,260, with 2 employees on average. Net assets fell 44% on the prior period (£273k).
Peer position · net assets
By net assets it sits in the top quarter of 278 comparable companies in Other (median £129, upper quartile £59k).
02
Ownership and control
- Dr Jonathan Douglas Collins
- owns 25–50% of shares
- holds 50–75% of voting rights
- Mrs Jennifer Elizabeth Collins
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 24 May 200521 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 7 June 2027in 227 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£2,260
−99%vs Mar 2024Not reported
2
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £154k | £2,260 | £437 | — | — | — | 2 |
| 31 March 2024 | £273k | £177k | £1,156 | — | — | — | 2 |
Cash per employee£1,130Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £154,045 at 31 March 2025
- Net assets down 25% or more on the prior period-43.6% vs prior period
- Incorporated five or more years agoIncorporated 24 May 2005
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 227 days
- Next accounts duein 69 days
- Accounts period endNet assets £154k · small accounts
- Accounts period endNet assets £273k · small accounts
- Incorporated
08
Similar companies in the UK
- EGERTON CLINICAL CONSULTING LIMITEDBray Shop · inc. Apr 2005
- GENEPRO LIMITEDPlymouth · inc. Nov 2004
- J R BIOMEDICAL LIMITEDSt. Asaph · inc. Dec 2005
- FOCUSMAIN LTDIpswich · inc. Sept 2004
- HIGHLAND BIOSCIENCES LTDDingwall · inc. Feb 2006
- PETER TREASURE STATISTICAL SERVICES LIMITEDKing'S Lynn · inc. Aug 2004
All companies incorporated on 24 May 2005 · in May 2005.
09
Reminders for MEDICINES DEVELOPMENT & LICENSING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.